T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis

Arthritis Research and Therapy

Volumn 10, Issue 6, 2008, Pages

  Du, Fang ^a   Lü, Liang Jing ^a   Fu, Qiong ^a   Dai, Min ^a   Teng, Jia Lin ^a   Fan, Wei ^a   Chen, Shun Le ^a   Ye, Ping ^a   Shen, Nan ^a   Huang, Xin Fang ^a   Qian, Jie ^a   Bao, Chun De ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN ANTIBODY; COLLAGEN TYPE 2 ANTIBODY; GAMMA INTERFERON; IGURATIMOD; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; METHOTREXATE; NIMESULIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; BENZOPYRAN DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTHROPATHY; ARTICLE; BONE EROSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IN VIVO STUDY; NONHUMAN; PAW EDEMA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; ANIMAL; ARTICULAR CARTILAGE; BLOOD; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; IMMUNOLOGY; KNEE; PATHOLOGY; WISTAR RAT;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BENZOPYRANS; CARTILAGE, ARTICULAR; DRUG THERAPY, COMBINATION; FEMALE; INFLAMMATION MEDIATORS; KNEE JOINT; METHOTREXATE; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 57649112539     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2554     Document Type: Article

References (49)

1. Tanaka K Yamamoto T Aikawa Y Kizawa K Muramoto K Matsuno H Muraguchi A Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice Rheumatology (Oxford) 2003, 42:1365-1371 10.1093/ rheumatology/keg381 12810927
2. Sawada T Hashimoto S Tohma S Nishioka Y Nagai T Sato T Ito K Inoue T Iwata M Yamamoto K Inhibition of L-leucine methyl ester mediated killing of THP-1, a human monocytic cell line, by a new anti-inflammatory drug, T614 Immunopharmacology 2000, 49:285-294 10.1016/S0162-3109(00)00242-3 10996026
3. Tanaka K Kawasaki H Kurata K Aikawa Y Tsukamoto Y Inaba T T-614, a novel antirheumatic drug, inhibits both the activity and induction of cyclooxygenase-2 (COX-2) in cultured fibroblasts Jpn J Pharmacol 1995, 67:305-314 10.1254/jjp.67.305 7650864
4. Lu LJ Teng JL Bao CD Han XH Sun LY Xu JH Li XF Wu HX Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial Chin Med J (Engl) 2008, 121:615-619 18466681
5. Scrivo R Di Franco M Spadaro A Valesini G The immunology of rheumatoid arthritis Ann N Y Acad Sci 2007, 1108:312-322 10.1196/annals.1422.033 17893995
6. Lutzky V Hannawi S Thomas R Cells of the synovium in rheumatoid arthritis. Dendritic cells Arthritis Res Ther 2007, 9:219-231 2206384 17850683 10.1186/ar2200
7. Du F Wang L Zhang Y Jiang W Sheng H Cao Q Wu J Shen B Shen T Zhang JZ Bao C Li D Li N Role of GADD45 beta in the regulation of synovial fluid T cell apoptosis in rheumatoid arthritis Clin Immunol 2008, 128:238-247 10.1016/j.clim.2008.03.523 18501677
8. Andreas K Lubke C Haupl T Dehne T Morawietz L Ringe J Kaps C Sittinger M Key regulatory molecules of cartilage destruction in rheumatoid arthritis: An in vitro study Arthritis Res Ther 2008, 10:R9-25 2374452 18205922 10.1186/ar2358
9. Aarvak T Chabaud M Miossec P Natvig JB IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells J Immunol 1999, 162:1246-1251 9973376
10. Lubberts E Koenders MI Berg van den WB The role of T-cell interleukin-17 in conducting destructive arthritis: Lessons from animal models Arthritis Res Ther 2005, 7:29-37 1064899 15642151 10.1186/ar1478
11. Hwang SY Kim JY Kim KW Park MK Moon Y Kim WU Kim HY IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways Arthritis Res Ther 2004, 6:R120-128 400429 15059275 10.1186/ar1038
12. Granet C Maslinski W Miossec P Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes Arthritis Res Ther 2004, 6:R190-198 416439 15142264 10.1186/ ar1159
13. Kehlen A Pachnio A Thiele K Langner J Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: Upregulation of hyaluronan-binding protein TSG-6 Arthritis Res Ther 2003, 5:R186-192 165059 12823853 10.1186/ar762
14. Van Bezooijen RL Wee-Pals Van Der L Papapoulos SE Lowik CW Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro Ann Rheum Dis 2002, 61:870-876 1753923 12228154 10.1136/ard.61.10.870
15. Chabaud M Garnero P Dayer JM Guerne PA Fossiez F Miossec P Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis Cytokine 2000, 12:1092-1099 10.1006/cyto.2000.0681 10880256
16. Kotake S Udagawa N Takahashi N Matsuzaki K Itoh K Ishiyama S Saito S Inoue K Kamatani N Gillespie MT Martin TJ Suda T IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis J Clin Invest 1999, 103:1345-1352 408356 10225978 10.1172/JCI5703
17. Gierer P Ibrahim S Mittlmeier T Koczan D Moeller S Landes J Gradl G Vollmar B Gene expression profile and synovial microcirculation at early stages of collagen-induced arthritis Arthritis Res Ther 2005, 7:R868-876 1175036 15987489 10.1186/ar1754
18. Shou J Bull CM Li L Qian HR Wei T Luo S Perkins D Solenberg PJ Tan SL Chen XY Roehm NW Wolos JA Onyia JE Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model Arthritis Res Ther 2006, 8:R28-42 1526586 16507131 10.1186/ar1883
19. Lubberts E Joosten LA Oppers B Bersselaar van den L Coenen-de Roo CJ Kolls JK Schwarzenberger P Loo van de FA Berg van den WB IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis J Immunol 2001, 167:1004-1013 11441109
20. Lubberts E Koenders MI Oppers-Walgreen B Bersselaar van den L Coenen-de Roo CJ Joosten LA Berg van den WB Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion Arthritis Rheum 2004, 50:650-659 10.1002/art.20001 14872510
21. Nakae S Nambu A Sudo K Iwakura Y Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice J Immunol 2003, 171:6173-7 14634133
22. Cho ML Ju JH Kim KW Moon YM Lee SY Min SY Cho YG Kim HS Park KS Yoon CH Lee SH Park SH Kim HY Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB Immunol Lett 2007, 108:88-96 10.1016/j.imlet.2006.11.001 17161467
23. Zaba LC Cardinale I Gilleaudeau P Sullivan-Whalen M Suarez Farinas M Fuentes-Duculan J Novitskaya I Khatcherian A Bluth MJ Lowes MA Krueger JG Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses J Exp Med 2007, 204:3183-3194 2150965 18039949 10.1084/jem.20071094
24. Rosloniec EF Cremer M Kang A Myers LK Collagen-induced arthritis Curr Protoc Immunol 2001 Chapter 15 Unit 15.5. 18432737
25. Brahn E Banquerigo ML Firestein GS Boyle DL Salzman AL Szabo C Collagen induced arthritis: Reversal by mercaptoethylguanidine, a novel antiinflammatory agent with a combined mechanism of action J Rheumatol 1998, 25:1785-1793 9733461
26. Ostergaard M Peterfy C Conaghan P McQueen F Bird P Ejbjerg B Shnier R O'Connor P Klarlund M Emery P Genant H Lassere M Edmonds J OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system J Rheumatol 2003, 30:1385-1386 12784422
27. Goronzy JJ Weyand CM Rheumatoid arthritis Immunol Rev 2005, 204:55-73 10.1111/j.0105-2896.2005.00245.x 15790350
28. Sweeney SE Firestein GS Signal transduction in rheumatoid arthritis Curr Opin Rheumatol 2004, 16:231-237 10.1097/00002281-200405000-00011 15103250
29. Chopin F Garnero P le Henanff A Debiais F Daragon A Roux C Sany J Wendling D Zarnitsky C Ravaud P Thomas T Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis Ann Rheum Dis 2008, 67:353-357 10.1136/ard.2007.076604 17644538
30. Nishimoto N Kishimoto T Interleukin 6: From bench to bedside Nat Clin Pract Rheumatol 2006, 2:619-626 10.1038/ncprheum0338 17075601
31. Cruyssen Vander B Van Looy S Wyns B Westhovens R Durez P Bosch Van den F Mielants H De Clerck L Peretz A Malaise M Verbruggen L Vastesaeger N Geldhof A Boullart L De Keyser F Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: Attrition and long-term evolution of disease activity Arthritis Res Ther 2006, 8:R112-R119 1779428 16978395 10.1186/ar2001
32. Carmona L Gomez-Reino JJ Rodriguez-Valverde V Montero D Pascual-Gomez E Mola EM Carreno L Figueroa M Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists Arthritis Rheum 2005, 52:1766-1772 10.1002/art.21043 15934089
33. Brassard P Kezouh A Suissa S Antirheumatic drugs and the risk of tuberculosis Clin Infect Dis 2006, 43:717-722 10.1086/506935 16912945
34. Dixon WG Watson K Lunt M Hyrich KL Silman AJ Symmons DP Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register Arthritis Rheum 2006, 54:2368-2376 10.1002/art.21978 16868999
35. Saag KG Teng GG Patkar NM Anuntiyo J Finney C Curtis JR Paulus HE Mudano A Pisu M Elkins-Melton M Outman R Allison JJ Suarez Almazor M Bridges SL Jr Chatham WW Hochberg M MacLean C Mikuls T Moreland LW O'Dell J Turkiewicz AM Furst DE American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis Arthritis Rheum 2008, 59:762-784 10.1002/art.23721 18512708
36. Bathon JM Cohen SB The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Where the rubber meets the road Arthritis Rheum 2008, 59:757-759 10.1002/art.23723 18512712
37. Lange F Bajtner E Rintisch C Nandakumar KS Sack U Holmdahl R Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis Ann Rheum Dis 2005, 64:599-605 1755430 15345503 10.1136/ ard.2004.026120
38. Jacobson PB Morgan SJ Wilcox DM Nguyen P Ratajczak CA Carlson RP Harris RR Nuss M A new spin on an old model: In vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat Arthritis Rheum 1999, 42:2060-2073 10.1002/ 1529-0131(199910)42:10<2060::AID-ANR6>3.0.CO;2-L 10524677
39. Koenders MI Lubberts E Loo van de FA Oppers-Walgreen B Bersselaar van den L Helsen MM Kolls JK Di Padova FE Joosten LA Berg van den WB Interleukin-17 acts independently of TNF-alpha under arthritic conditions J Immunol 2006, 176:6262-6269 16670337
40. Chabaud M Page G Miossec P Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: Regulation by soluble receptors and Th2 cytokines J Immunol 2001, 167:6015-6020 11698482
41. Lubberts E IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis? Cytokine 2008, 41:84-91 10.1016/ j.cyto.2007.09.014 18039580
42. Aikawa Y Yamamoto M Yamamoto T Morimoto K Tanaka K An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation Inflamm Res 2002, 51:188-194 10.1007/PL00000291 12058956
43. Zhou L Ivanov II Spolski R Min R Shenderov K Egawa T Levy DE Leonard WJ Littman DR IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways Nat Immunol 2007, 8:967-974 10.1038/ni1488 17581537
44. Yoshizaki K Nakagawa T Fukunaga K Tseng LT Yamamura Y Kishimoto T Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line J Immunol 1984, 132:2948-2954 6202767
45. Nakahara H Song J Sugimoto M Hagihara K Kishimoto T Yoshizaki K Nishimoto N Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis Arthritis Rheum 2003, 48:1521-1529 10.1002/art.11143 12794819
46. Tamura T Udagawa N Takahashi N Miyaura C Tanaka S Yamada Y Koishihara Y Ohsugi Y Kumaki K Taga T Kishimoto T Suda T Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6 Proc Natl Acad Sci USA 1993, 90:11924-11928 48097 8265649 10.1073/pnas.90.24.11924
47. Terato K Hasty KA Reife RA Cremer MA Kang AH Stuart JM Induction of arthritis with monoclonal antibodies to collagen J Immunol 1992, 148:2103-2108 1545120
48. Zheng B Zhang X Guo L Han S IgM plays an important role in induction of collagen-induced arthritis Clin Exp Immunol 2007, 149:579-585 2219323 17590174
49. Nandakumar KS Johansson BP Bjorck L Holmdahl R Blocking of experimental arthritis by cleavage of IgG antibodies in vivo Arthritis Rheum 2007, 56:3253-3260 10.1002/art.22930 17907170